Study: Ivermectin Didn’t Fare Better Against COVID Than Placebo

A new study found that patients who were treated for COVID-19 with ivermectin didn't fare better than those who received a placebo.

A new study found that patients who were treated for COVID-19 with ivermectin didn’t fare better than those who received a placebo.

Ivermectin was pushed by several fringe “experts” who said they had great success with the anti-parasitic drug in treating COVID-19, but those claims were based on poor quality data or anecdotal evidence. The FDA implored people not to self-treat with the drug.

Via MarketWatch:

Public-health authorities and researchers have for months said the drug hasn’t shown any benefit in treating the disease. Taking large doses of the drug is dangerous, the Food and Drug Administration has said.

The latest trial, of nearly 1,400 Covid-19 patients at risk of severe disease, is the largest to show that those who received ivermectin as a treatment didn’t fare better than those who received a placebo.

“There was no indication that ivermectin is clinically useful,” said Edward Mills, one of the study’s lead researchers and a professor of health sciences at Canada’s McMaster University in Hamilton, Ontario.

Dr. Mills on Friday plans to present the findings, which have been accepted for publication in a major peer-reviewed medical journal, at a public forum sponsored by the National Institutes of Health.

Now, THAT’s how you do research, folks. Not by hunting down a YouTube video that aligns with your own opinion.